Ben Lü
Impact in
- Clinical Biochemistry top 0.2%
- Advanced Glycation End Products research
- Immunology top 2%
- Immune Response and Inflammation
- interferon and immune responses
Papers in
-
- Advanced Glycation End Products research 9
- Immunology 16
- Immune Response and Inflammation 13
- interferon and immune responses 2
- Co-authors
- Haichao Wang (17 shared papers)Kevin J. Tracey (14 shared papers)Sangeeta S. Chavan (10 shared papers)Jianhua Li (9 shared papers)Yiting Tang (20 shared papers)Helena Erlandsson-Harris (4 shared papers)Huan Yang (5 shared papers)Timothy R. Billiar (14 shared papers)
- Journals
- Molecular Medicine (4 papers)Journal of Biological Chemistry (3 papers)Nature Communications (3 papers)Shock (3 papers)Immunity (3 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Ben Lü
51 papers receiving 5.2k citations
Ben Lü's Hit Papers
Peers
Comparison fields: 5 of 113
- Clinical Biochemistry 913
- Immunology 1.1k
- Neurology 299
- Biological Psychiatry 35
- Molecular Biology 1.6k
Countries citing papers authored by Ben Lü
This map shows the geographic impact of Ben Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Lü more than expected).
Fields of papers citing papers by Ben Lü
This network shows the impact of papers produced by Ben Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Lü. The network helps show where Ben Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Ben Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 704 | |
| 2 | Novel role of PKR in inflammasome activation and HMGB1 release Hit paper breakdown → | 2012 | 671 |
| 3 | The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis Hit paper breakdown → | 2018 | 480 |
| 4 | 2014 | 322 | |
| 5 | 2015 | 319 | |
| 6 | 2019 | 266 | |
| 7 | 2013 | 189 | |
| 8 | 2014 | 175 | |
| 9 | Intrinsic Radical Species Scavenging Activities of Tea Polyphenols Nanoparticles Block Pyroptosis in Endotoxin-Induced Sepsis Hit paper breakdown → | 2022 | 153 |
| 10 | 2013 | 143 | |
| 11 | 2014 | 134 | |
| 12 | 2021 | 123 | |
| 13 | 2020 | 122 | |
| 14 | 2021 | 118 | |
| 15 | 2022 | 118 | |
| 16 | 2015 | 117 | |
| 17 | 2023 | 79 | |
| 18 | 2013 | 70 | |
| 19 | 2020 | 70 | |
| 20 | 2015 | 67 |
About Ben Lü
Ben Lü is a scholar working on Clinical Biochemistry, Immunology, Molecular Biology, Epidemiology and Hematology, having authored 53 papers that have together received 5.2k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (22 papers), Immune Response and Inflammation (13 papers), Sepsis Diagnosis and Treatment (10 papers), Advanced Glycation End Products research (9 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), interferon and immune responses (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers) and Systemic Lupus Erythematosus Research (2 papers). The work is most often cited by research in Clinical Biochemistry (913 citations), Immunology (1.1k citations), Neurology (299 citations), Biological Psychiatry (35 citations) and Molecular Biology (1.6k citations). Ben Lü has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Haichao Wang, Kevin J. Tracey, Sangeeta S. Chavan, Jianhua Li, Yiting Tang, Helena Erlandsson-Harris, Huan Yang, Timothy R. Billiar, Kai Zhao and Daniel James Antoine. Their work appears in journals such as Molecular Medicine, Journal of Biological Chemistry, Nature Communications, Shock and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.